Skip to main content

Navigation group

Type at least 3 characters
1,205 articles

Articles

Original Research

Published on 08 Oct 2020

Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients

in Cardiovascular and Smooth Muscle Pharmacology

  • Vincenzo Russo
  • Andreina Carbone
  • Filiberto Fausto Mottola
  • Rosa Mocerino
  • Raffaele Verde
  • Emilio Attena
  • Nicoletta Verde
  • Pierpaolo Di Micco
  • Luigi Nunziata
  • Francesco Santelli
Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients
Frontiers in Pharmacology
doi 10.3389/fphar.2020.582348
  • 4,221 views
  • 16 citations